Drug Shortage Report for MYLAN-INDAPAMIDE
Report ID | 154043 |
Drug Identification Number | 02240067 |
Brand name | MYLAN-INDAPAMIDE |
Common or Proper name | INDAPAMIDE |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | INDAPAMIDE |
Strength(s) | 1.25MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100BT |
ATC code | C03BA |
ATC description | LOW-CEILING DIURETICS, EXCL THIAZIDES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2022-02-09 |
Actual start date | |
Estimated end date | 2022-02-15 |
Actual end date | 2022-01-19 |
Shortage status | Avoided shortage |
Updated date | 2022-02-25 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2022-02-25 | French | Compare |
v5 | 2022-02-25 | English | Compare |
v4 | 2022-02-25 | English | Compare |
v3 | 2022-02-10 | English | Compare |
v2 | 2022-02-02 | French | Compare |
v1 | 2022-02-02 | English | Compare |
Showing 1 to 6 of 6